Sarah M. Melhorn
Papers
1
Total Citations
1
H-Index
1
About
Dr. Sarah M. Melhorn is a pioneering researcher in advanced drug delivery systems, with a focused expertise in developing single-injection, pulsatile-release platforms for global health challenges. Her most notable work addresses the critical burden of rabies post-exposure prophylaxis in low- and middle-income countries (LMICs), where the current multi-dose regimen over several weeks is often impractical. Dr. Melhorn’s key contribution lies in the fabrication of pulsatile polymeric microparticles that encapsulate rabies antigen, designed to release the vaccine in timed pulses, mimicking the standard immunization schedule from a single injection. This innovation has the potential to dramatically improve vaccine compliance and accessibility in resource-limited settings. Her foundational paper on this topic has garnered attention for its direct translational impact, aiming to reduce the logistical and financial barriers that contribute to the tens of thousands of rabies deaths annually. By engineering a platform that could revolutionize how vulnerable populations receive life-saving vaccines, Dr. Melhorn is at the forefront of creating equitable, patient-centered solutions in global health and biomaterials engineering.
Research Focus
Key Achievements
Top Papers
- 1